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ABSTRACT  
Current molecular assays for detecting Dirofilaria immitis DNA in mosquitoes by 
PCR cannot differentiate between infected mosquitoes that contain any stage of the 
parasite and infective mosquitoes that harbor third-stage parasite larvae (L3). This over-
estimates transmission risks to canines because only L3 D. immitis are capable of 
establishing infections in canines. I have developed an assay that detects D. immitis L3 in 
the vector Aedes aegypti based on a reverse transcriptase-polymerase chain reaction (RT-
PCR) method that detects an L3-activated gene transcript. Potential L3 stage genes were 
identified using bioinformatics tools and were screened by PCR using complementary 
DNA (cDNA) libraries as templates. Candidate genes were screened for stage-specific 
expression using RNA isolated from both D. immitis infected and uninfected mosquitoes. 
RT-PCR was performed using primer sets specific for each candidate gene. The L3 
specific gene transcript CK855471A was only detected in infective mosquitoes. This L3- 
activated gene transcript and a constitutively expressed control transcript, Ditph, for all 
vector-stage filarial larvae can be used to detect filarial infectivity in pools of 25 
mosquitoes. This assay may be useful for examining the seasonality of transmission, and 
D. immitis gene regulation. 
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Chapter I 
  INTRODUCTION 
Dog heartworm is a canine disease caused by infection with the filarial nematode 
Dirofilaria immitis (Ledesma and Harrington 2011). This mosquito vector-transmitted 
parasite commonly infects dogs, but infections also have been detected in cats (Bowman 
and Atkins 2009), coyotes (Sacks et al., 2004), foxes, sea lions, penguins (Sano et al., 
2005) and even humans under very rare conditions (Simón et al., 2009; Ledesma and 
Harrington 2011). Sixty-three species of mosquitoes are thought to be potential vectors of 
D. immitis, including twenty-eight species in North America (Ludlam et al., 1970). 
Although once confined to the southern United States, D. immitis now occurs in most 
locations where potential vectors are found (Acha and Szyfres 2003; Licitra et al., 2010). 
The majority of the vectors belong to the genera Aedes, Anopheles and Culex (Ludlam et 
al., 1970). Although over sixty mosquito species have been identified as vectors, the 
vector competence of most species remains unknown.  
The risk of canine infection by D. immitis depends on a combination of several 
factors related to the definitive and intermediate hosts (Capelli et al., 2013). The 
likelihood of infection in the intermediate host depends on vector competence, host 
seeking activity, feeding preference and vector densities (Capelli et al., 2013). 
Heartworm infections pose a significant risk to canines because any infection is sufficient 
to produce pulmonary vascular and parenchymal disease (Brown et al., 2012). Chronic  
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infections are caused by D. immitis adults residing within the right ventricle and 
pulmonary arteries (Licitra et al., 2010). Many dogs show little or no sign of infection 
even after the worms become adults although one early sign is a cough. In more advanced 
cases, where worms may have accumulated in the heart without treatment, more severe 
symptoms occur such as weight loss, fainting, and congestive heart failure (Bowman and 
Atkins 2009). The Companion Animal Parasite Council (CAPC) examined results of 
4,769,403 canine heartworm tests during the 2011 calendar year and found that 56,612 
(1.2%) had heartworm antigens indicating an active D. immitis infection (Brown et al., 
2012). Despite improved diagnostic methods, increased awareness among veterinarians 
and pet owners, and effective preventives, heartworm infections are diagnosed frequently 
and are becoming more prevalent in areas previously considered to be at low risk 
(Bowman et al., 2009). In order to reduce D. immitis incidents researchers must better 
understand its lifecycle. 
The complete lifecycle of D. immitis consists of four developmental stages: 
microfilariae (Mf), larvae (L1-L4), juvenile adults and adult worms. Dogs, the definitive 
host, become infected when third stage larvae (L3) exit the labium of infected 
mosquitoes, the intermediate host, during a blood meal. The L3 move across the host’s 
skin and enter through the mosquito feeding site. At the site of inoculation the L3 molt to 
fourth stage larvae (L4) in the muscles and submuscular membrane of the definitive host. 
The larvae develop into juvenile adults, enter the bloodstream through the surrounding 
vasculature and migrate to the host’s pulmonary arteries. Adult worms reproduce 
sexually, and microfilariae produced by gravid females are released into the peripheral 
blood (Ledesma and Harrington 2011).  
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Mosquitoes become infected with D. immitis when they ingest the Mf while blood 
feeding on an infected dog (Brown et al., 2012). After ingestion, Mf migrate from the 
mosquito’s midgut to the Malpighian tubules in the abdomen. There the parasites develop 
into the first-stage larvae (L1) and second-stage larvae (L2) (Ledesma and Harrington 
2011). The L2 exit the Malpighian tubules and migrate through the mosquito body cavity 
(hemocoel) from the abdomen to the head where they molt to the infective (L3) stage. 
The L3 move to the mosquito’s proboscis, emerge from the labium when it takes a blood 
meal and infects another definitive host (Ledesma and Harrington 2011). To be a 
competent vector of D. immitis, mosquitoes must support nematode development through 
the L3 stage. Not all Mf ingested by mosquitoes survive and become infective L3 (Laney 
et al., 2010).     
In the past, potential vectors were identified by dissecting field-collected 
mosquitoes to look for L3 development (Licitra et al., 2010). This technique is labor 
intensive, not conductive to identifying life stages, and impractical for screening large 
numbers of mosquitoes (Sauerman and Nayar 1983). An alternative diagnostic test for D. 
immitis DNA using polymerase chain reaction (PCR) was developed to identify infective 
mosquitoes (Scoles and Kambhampati 1995; Watts et al., 2001). Studies by Chambers et 
al. (2009) and Fisher et al. (2007) that compared these two techniques found that PCR 
produced a higher detection rate than dissection and allowed more samples to be 
analyzed simultaneously while reducing human error. Unfortunately, the Scoles and 
Kambhampati (1995) assay detects DNA from all parasite stages and therefore does not 
accurately measure population transmission potential because it does not differentiate 
between infected and infective mosquitoes. Thus, the Scoles and Kambhampati (1995) 
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PCR estimates parasite prevalence rather than infectivity because the Mf ingested by a 
mosquito do not all survive and develop into infective L3 (Laney et al., 2010). To directly 
assess transmission potential the presence of L3 in a vector population must be evaluated.  
An assay that specifically targets D. immitis L3 would be useful for answering 
research questions about the seasonality of transmission and D. immitis gene regulation. 
Such an assay would also be valuable for identifying or confirming mosquito species that 
are vectors in geographic regions where heartworm is emerging. Recent studies have 
found new geographic regions in Europe (e.g., Italy Spain and Turkey) where previously 
unknown vectors (e.g., Culex pipiens) of D. immitis have been identified (Capelli et al., 
2013; Morchón et al., 2007; Yildirim et al., 2011). The discovery of new vector species 
provides further rationale for the development of a highly sensitive method for 
monitoring transmission potential. The research reported here identifies a D. immitis L3 
stage-specific activated gene and an L3 detection assay for the presence or absence of 
infective stage D. immitis in mosquito vectors using reverse transcriptase polymerase 
chain reaction (RT-PCR).  
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Chapter II  
MATERIALS AND METHODS 
Search Strategy for L3-activated Candidate Genes  
Cuticlin genes in nematode parasites that are activated at the L3 stage (Liu et al., 
1995) have been successfully used as markers for identifying L3 stage parasites in the 
human filarial worms Brugia malayi (Laney et al., 2008) and Wuchereria bancrofti 
(Laney et al., 2010). Therefore, selection of potentially diagnostic D. immitis candidate 
genes focused primarily on identifying D. immitis genes orthologous to B. malayi and W. 
bancrofti cuticle genes. Supplementary L3-activated gene sequences from B. malayi, W. 
bancrofti, and Caenorhabditis elegans1 databases were also screened. Potential candidate 
gene sequences were identified by bioinformatics analysis of Expressed Sequence 
Tagged (EST) databases using nucleotide Basic Local Alignment Search Tool 
(BLASTN) available at http://xyala.cap.ed.ac.uk/downloads/959nematodegenomes/blast/ 
/filareu.php and screened against the D. immitis nuclear genome assembly 2.2 DNA 
sequence (Godel et al., 2012). Although, identification of L3-activated gene sequences 
was the primary objective, genes also expressed in the L4 through adult stages were not 
excluded.  
Primer Design 
                                                          
1 Caenorhabditis elegans dauer stage is thought to be analogous to the L3 stage of parasitic nematodes.  
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Potential target genes were screened using the mRNA-to-genomic DNA 
alignment program, SPIDEY (www.ncbi.nlm.nih.gov/spidey) (Wheelan et al., 2001),
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which readily identifies intron-exon junctions in order to prevent detection of genomic 
DNA (gDNA) in complementary DNA (cDNA) library preparations (Laney et al., 2008; 
Laney et al., 2010). Specific primers were designed for each candidate gene using 
Primer-BLAST software (http://www.ncbi.nlm.nih.gov/tools/primer-blast/) (Ye et al., 
2012). The criterion used to create each primer was as follows: 1) one primer for each 
gene spanned an exon-exon boundary to prevent the amplification of gDNA, 2) sequence 
length ranged between 17 and 23 nucleotides, 3) melting temperatures (Tm) were between 
55ιC and 60ιC, and within 2ιC of each other, 4) GC content ranged between 33.0% to 
69.0%, 5) When possible, G or C bases were within the last 5 bases from the 3’ end to 
promote GC clamp binding, 6) product sizes ranged between 190 and 570 base pairs (bp), 
and 7) when possible, self-complementarity values below 8 and self 3’complementarity 
values lower than 6 were used to avoid primer dimers and hairpins. At least one primer 
set was created for each candidate gene. More primer sets were created depending upon 
the number of intron-exon boundaries detected. All primer sequences used in this study 
are listed in Table 1.  
Pre-Screening of Candidate L3-activated Genes using mRNA Libraries 
Converting mRNA libraries to cDNA libraries was performed using the 
SuperScript® IV First-Strand Synthesis System Kit (Invitrogen Life Technologies, Grand 
Island, NY) following the manufacturer’s protocol. Each reaction (20 μL) included 50 
μM Oligo d(T)20 primer, 10mM dNTP mix, DEPC-treated water, 5x SSIV Buffer, 100 
mM DTT, RNaseOUT™ Recombinant RNase Inhibitor and SuperScript® IV Reverse 
Transcriptase. PCR used template (5 μL) from stage-specific mRNA libraries: DiMf and 
DiL3 (available at http://www.filariasiscenter.org/). Candidate genes were screened for 
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L3 stage-specific expression by RT-PCR with the Platinum® Taq DNA Polymerase kit 
(Invitrogen Life Technologies, Grand Island, NY). The Platinum® Taq DNA Polymerase 
kit was used according to manufacturer’s instructions except that a 2.5 mM dNTP mix 
was used instead of 10 mM (volume used was equivalent to 10 mM), and the total 
volume was adjusted from 50 μL to 25 μL.  
Each 25 μL PCR reaction contained buffer without magnesium chloride (MgCl2), 
1.5 mM MgCl2, 100 μM each of dATP, dCTP, dGTP, and dTTP (Fisher Scientific, 
Pittsburgh, PA, USA), 0.2 μM of the forward and reverse primers, 0.2 μM Platinum® 
Taq DNA polymerase, and 2 μL template cDNA. The PCR cycling parameters used were 
94 °C for 2 min followed by 35 cycles of 94 °C for 30 s, 55 °C for 30 s, 72 °C for 1 min, 
and a final extension held indefinitely at 4 °C. PCR products were size fractionated by 
electrophoresis on 3% agarose gels (Fisher Scientific, Pittsburgh, PA) stained with 
GelRed (Biotium, Hayward, CA), run at 70V for 1.5 h. Results were visualized using an 
ImageQuant LAS 4000 (GE Healthcare, Pittsburgh, PA, USA) with ultraviolet light. The 
primers used in the multiplex RT-PCR for the control gene Ditph amplify a 152 bp 
fragment from all stages of the parasite (Ditph F 5’-AAGGTCGACAAGTGGTGAGAA-
3’ and Ditph R 5’-GTAGCCATATCTTCGTAACAGTTC-3’) to ensure RNA sample 
degradation had not occurred. The Ditph primer sequence was designed based upon a D. 
immitis orthologue that was identified following bioinformatics screening of a 
constitutively expressed tph-1 from W. bancrofti (Accession # CD374712.1). Candidate 
genes were excluded from further consideration if DiMf amplification products were 
detected or if no product was detected for DiL3 cDNA library.   
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Parasite Infection of Mosquitoes 
Aedes aegypti black-eyed mosquitoes infected with the Missouri 2005 strain of D. 
immitis was provided by the NIH/NIAID Filariasis Research Reagent Resource (FR3) 
Center at the University of Georgia (http://www.filariasiscenter.org). Animals used by 
the FR3 Center (www.filariasiscenter.org) were handled according to the NIH guidelines 
for animal experimentation and the animal experimental protocols were approved by the 
University of Georgia and the University Institutional Animal Care and Use Committee 
under the protocol number: A2013 11-009, respectively. The animal care and use 
protocols adhered to the “Guide for the Care and Use of Laboratory Animals (the Guide)” 
published by the National Research Council, USA. The mosquitoes were fed on blood 
maintained at approximately 37 °C from an infected animal containing the Mf stage of 
the parasite using a membrane feeding apparatus. The microfilaremia in the blood ranged 
from 70 to 90 Mf per 20 μL. Mosquitoes were collected at 2, 5, 10 and 14 days post 
infection (d.p.i) and immediately snap frozen. These time points extend across the 
lifecycle of D. immitis and were used to examine expression profiles. The FR3 center also 
provided uninfected mosquitoes (unfed or after feeding on blood from uninfected cats) to 
serve as a control in this experiment. This study was approved by the Valdosta State 
University Biosafety Committee (see Appendix A and B). 
RT-PCR Testing of Putative Target Genes against Mosquito Pools 
RNA from pools of 25 Ae. aegypti mosquitoes was extracted using a total RNA 
isolation protocol modified (i.e., based on the Invitrogen protocol for total RNA 
isolation) for mosquitoes from the University of Notre Dame. See Appendix C for 
detailed protocol. After extraction, RNA samples (1.5 μL) were evaluated using a 
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NanoDrop 2000 spectrophotometer (Thermo Scientific, Waltham, MA, USA) for purity 
(260/280 nanometer wavelengths) and quantity (nucleic acid concentration). RNA 
samples were then immediately converted to cDNA and RT-PCR was performed as 
described above. Potential target genes were screened against a negative RNA extraction 
control from a pool of uninfected mosquitoes, a positive RNA extraction control from a 
pool of infective 14 d.p.i mosquitoes, and genomic DNA (gDNA) to ensure that only the 
expressed D. immitis target genes were detected. Candidate genes were not evaluated for 
further testing if amplification of uninfected pools or gDNA occurred.  
Time-Course Screening with L3 Specific Primers 
RNA extraction, cDNA synthesis, and conventional RT-PCR, as previously 
described, was performed on cohorts of 25 female mosquitoes fed on D. immitis infected 
blood and held at 2, 5, 10, and 14 d.p.i as previously stated. Three biological repeats of 
all the time points were tested. 
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Chapter III 
RESULTS 
cDNA Library Multiplex RT-PCR 
Table 2 lists the candidate L3-activated gene targets generated from 
bioinformatics searches that met the previously described criteria. Table 2 also shows 
stage expression for each candidate gene based on PCR amplification from a D. immitis 
Mf and D. immitis L3 mRNA library (D. immitis mRNA libraries for the L1, L2, and L4 
stages were unavailable) that had been converted to a cDNA library. Five potential target 
genes that exhibited L3 stage expression were identified. Two genes had multiple primers 
created based upon different regions of the gene; CB338725 has 2 different primers (A-
B) and CK855471 has 6 (A-F). Therefore, we screened eleven primer sets in total. 
One of eleven target gene candidates tested (CB338725A) had transcripts 
expressed in the D. immitis Mf cDNA library and was not considered for further analysis. 
Four candidate genes (CK855471B, CK855471D, CK855471E and CK854857) showed 
no amplification in the D. immitis L3 cDNA library. These candidate genes were deemed 
to not accurately identify infective mosquitoes and were discarded. In two candidate 
genes, H98312 and CB338725B, PCR amplification was inconclusive by multiplex PCR 
due to a small difference in product sizes. These genes were tested further by 
conventional PCR to ensure Mf and L3 cDNA amplification had not occurred. H98312 
did not show amplification for either of the D. immitis cDNA libraries and was 
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eliminated from further testing. Five target candidate genes (CB338725B, CK850096, 
CK855471A, CK855471C, and CK855471F) were selected for further testing as 
diagnostic targets based on amplification in the L3 stage cDNA library and constitutively 
expressed gene (Ditph) with no amplification in the microfilariae stage cDNA library. 
Conventional RT-PCR of Candidate Genes against Mosquito Pools  
The five selected gene candidates were tested using RNA isolated from infective 
mosquito pools collected 14 d.p.i, uninfected mosquito pools and gDNA from the 
infective mosquito pools. The W. bancrofti L3-activated collagen gene, CK855471A, was 
amplified in D. immitis infective mosquitoes at 14 d.p.i but did not amplify in genomic 
DNA from infected mosquitoes nor did it amplify cDNA from uninfected mosquitoes. 
The remaining four candidate genes were eliminated as diagnostic targets because 
conventional RT-PCR results indicated that none of them showed expression for 
infective, uninfected or gDNA mosquito pools (Table 3). The CK855471A target was 
determined to be the best target for an L3 detection assay.  
Conventional RT-PCR of CK855471A and Ditph using Time-Course Study  
High quality RNA was extracted from pools of infective mosquitoes fed on 
microfilaremic blood as well as uninfected mosquitoes and snap frozen using the protocol 
previously mentioned. The nucleic acid concentration of RNA yielded from the 
uninfected, 2, 5, 10, and 14 d.p.i time-course samples had a mean of 2718.9, 3638.3, 
908.3, 2378.3, and 1986.3 ng/μL, respectively, and a standard deviation of 1000.6 ng/μL. 
The ratio of absorbance readings between 260 and 280 nanometer wavelengths had a 
mean of 2.18, 2.14, 2.16, 2.18, and 2.14, respectively, and a standard deviation of 0.02 
indicating high purity RNA was extracted from all samples (Table 4).  
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The CK855471A primer set amplified a 286bp product from D. immitis Missouri 
2005 stage L3, while the primer set for Ditph amplified a 152bp fragment from all stages 
of the parasite. The RT-PCR assay primers were designed to span identifiable intron-
exon boundaries of D. immitis stage-specific candidate genes. The size difference 
between CK855471A and Ditph amplification products allowed them to be differentiated 
on a 3% agarose gel. Figure 1A upper panel shows expression of Ditph and Figure 1A 
lower panel shows expression of CK855471A in uninfected mosquitoes and mosquito 
pools at the different time points listed previously (2, 5, 10, and 14 d.p.i) using 
conventional RT-PCR. Figure 1B illustrates expression of Ditph and CK855471A against 
the same mosquito pools using multiplex RT-PCR. Ditph was detected in all mosquito 
pools, whereas CK855471A was not detected until 14 d.p.i in two of the three biological 
repeats; 10 d.p.i expression was found in one biological replicate. Microfilarial 
development to L3 can occur as early as 8 d.p.i (Ledesma and Harrington 2011) 
therefore, it is not unlikely to see L3 expression at 10 d.p.i; each pool of 25 mosquitoes 
parasite development is not synchronized. The CK855471A RT-PCR primers were 
specific for D. immitis samples; no expression was detected in mosquitoes with D. 
immitis Mf, uninfected control mosquitoes, and gDNA. 
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Table 1. Candidate Gene Primer Sequences. 
 
  
 
 Gene Identifier = Genebank Accession number available at http://www.ncbi.nlm.nih.gov/. 
 F = Forward Primer, R = Reverse Primer 
 
 
 
 
 
 
 
 
Gene Identifier Direction Sequence 5’→3’ 
H98312 F GAAGCACGAGAAAAAGCTTATAC 
H98312 R TCAGATGGTGGACGGTG 
CB338725A F GTTCGAGAAACAATTCGATGGTC 
CB338725A R CGGCTGCATCAACCTCTTTC 
CB338725B F CTATGTCAGTTATCGATCTCGCG 
CB338725B R CGGCTGCATCAACCTCTTTC 
CK8500976 F GCGATGATAATCAAGCTTTGCC 
CK8500976 R TTGGACGAAATTTAAACGAAATGG 
CK855471A F GAGAACGCGCATACAAGGC 
CK855471A R GGTTTGCAACAACTATCACAGGC 
CK855471B F GGAGCCTGTGATAGTTGTTGC 
CK855471B R CTGGTTCGCCCGGTTG 
CK855471C F GGAAACAGCGGTAGTGCTG 
CK855471C R CTGGTGGTCCATTTGGTCC 
CK855471D F GAGAACGCGCATACAAGGC 
CK855471D R CAGCACTACCGCTGTTTCC 
CK855471E F CTTCAATTTTGCAAATCCTCAGC 
CK855471E R CGCTGTTTCCTGGTCTGC 
CK855471F F GGAGCCTGTGATAGTTGTTGC 
CK855471F R CTGGTGGTCCATTTGGTCC 
CK854857 F CAGTGAATGTCCACGACCAC 
CK854857 R CTGGGTGACCATGATCGATG 
14 
 
Table 2. cDNA Library PCR Screening of Candidate Genes.  
 
 
Gene Identifier = Genebank Accession number available at http://www.ncbi.nlm.nih.gov/. 
+ = PCR product detected, - = no PCR product detected  
D. immitis cDNA library abbreviations: DiMf = microfilarial stage, DiL3 = infective L3 stage 
 
 
 
 
 
 
 
 
 
 
 
Gene Identifier Putative Identification 
based on Protein 
similarity matches 
DiMf cDNA 
Library 
DiL3 cDNA 
Library 
H98312 BM Collagen - - 
CB338725A BM Pyruvate + + 
CB338725B BM Pyruvate - + 
CK850096 WB Cuticlin 1.0 - + 
CK855471A WB Collagen - + 
CK855471B WB Collagen - - 
CK855471C WB Collagen - + 
CK855471D WB Collagen - - 
CK855471E WB Collagen - - 
CK855471F WB Collagen - + 
CK854857 WB Cuticlin 2.0 - - 
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Table 3. RT-PCR of Candidate Genes against Mosquito Pools.  
 
 
 
 
 
 
 
 
 
         
 
        Gene Identifier = Genebank Accession number available at http://www.ncbi.nlm.nih.gov/. 
        + = PCR product detected, - = no PCR product detected 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gene 
Identifier 
Infective 
mosquito cDNA 
Uninfected 
mosquito cDNA 
Infective 
gDNA 
CB338725B - - - 
CK850096 - - - 
CK855471A + - - 
CK855471C - - - 
CK855471F - - - 
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Table 4. RNA Extraction Quantity and Quality across Time-Course Study.  
  ng/μL of total RNA  260/280  
Mosquito 
Time 
point 
(#d.p.i) 
Expected 
Stage of 
Parasite 
Development 
 
Biological Replicates 
  
Biological 
Replicates 
 
  I II III Mean I II III Mean 
UI  3133.3 3671.6 1351.8 2718.9 2.20 2.18 2.17 2.18 
2 Mf 2332.2 2564.5 6018.3 3638.3 2.15 2.07 2.20 2.14 
5 L1 991.1 1235.0 498.9 908.3 2.18 2.16 2.13 2.16 
10 L2/L3 2638.2 1076.5 3420.1 2378.3 2.15 2.18 2.21 2.18 
 14 L3 2566.1 2416.4 976.4 1986.3 2.12 2.16 2.13 2.14 
                   Stdev      1000.6                    Stdev    
  
 0.02 
# d.p.i = number of days post infection (after mosquitoes were feed on infected blood) 
UI = Uninfected Ae. aegypti mosquito pool,         = no parasitic developmental stage  
260/280 = RNA purity as detected by spectrophotometry 
Stdev = standard deviation  
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Figure 1. RT-PCR Detection of Ditph 
and CK855471A in a Mosquito Time-Course.  
Time course A (conventional RT-PCR) and B (multiplex RT-PCR) illustrates no amplification of the W. 
bancrofti L3-activated collagen gene CK855471A (286 bp) in pre-L3 stages, while the control Ditph 
(152bp) is detected at all time points indicating the presence of parasite RNA. Upper Panel A shows Ditph 
tested against each time point as well as a negative control (uninfected mosquitoes). Lower Panel B shows 
CK855471A tested against each time point as well as a negative control (uninfected mosquitoes). 
d.p.i = days post infection (after mosquitoes were feed on infected blood)  
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Chapter IV 
DISCUSSION 
In this study, I have successfully identified a D. immitis L3-stage specific gene 
that can be used for the detection of mosquitoes capable of transmitting infective stage 
parasites. Our search strategy for identifying an L3 stage-specific gene transcript used 
bioinformatics analysis of EST datasets with a primary focus on D. immitis orthologues 
to cuticlin genes from both B. malayi (Laney et al., 2008) and W. bancrofti (Laney et al., 
2010). However, additional gene types (e.g. collagen and pyruvate) were also considered. 
This study identified five potential target genes, two of which had multiple primers 
created based upon different regions of the gene: CB338725 had 2 different primers (A-
B) and CK855471 had six (A-F). I screened a total of eleven primer sets and examined 
their expression against the following: 1) D. immitis Mf and L3 stage cDNA libraries 
using multiplex RT-PCR, 2) gDNA to ensure that only the expressed D. immitis target 
genes were detected, and 3) RNA extracted from uninfected mosquitoes and infected 
mosquitoes (2, 5, 10, and 14 d.p.i) using conventional RT-PCR. The W. bancrofti L3-
activated collagen gene CK855471A exhibited expression by conventional RT-PCR at 10 
d.p.i in one of three biological repeats. This corresponds to findings that L3 expression 
can be observed as early as 8 d.p.i (Ledesma and Harrington 2011). The discovery of this 
gene is identical to that of the L3 activated collagen gene TC8100 found in B. malayi by 
Laney et al. (2010). These were the only target gene that met the assay criteria of non-
amplification in gDNA or uninfected pools, and amplification in an L3 cDNA library. In
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addition to detecting CK855471A, a novel constitutively expressed gene (Ditph), for all 
parasitic stages was detected in each sample to ensure the presence of parasite transcripts. 
This allows both transmission risks and xenomonitoring to be evaluated simultaneously 
(Laney et al., 2010).  
This newly developed method has advantages over microscopic identification 
(Licitra et al., 2010), and standard PCR for parasite filarial DNA (Scoles and 
Kambhampati 1995). Standard PCR assays have been shown to exhibit increased 
sensitivity over dissection and can allow an increased number of samples to be analyzed 
simultaneously while reducing human error (Chambers et al., 2009; Fisher et al., 2007). 
Unfortunately, this technique misrepresents transmission potential because it detects 
DNA from all parasite stages in the mosquito and measures prevalence rather than 
infectivity. Also, using this technique non-competent mosquito vectors could be 
inaccurately identified as vectors. According to Fisher et al. (2007) parasite DNA can be 
detected in both vector and non-vector mosquitoes for two weeks or longer after they 
ingest Mf positive blood. A molecular assay that accurately identifies infectivity requires 
a method for preserving parasite RNA in mosquitoes, efficiently isolating and extracting 
parasite RNA from parasites in pools of mosquitoes, and identifying an L3-activated gene 
transcript to ensure only infective stage parasites are detected (Laney et al., 2008; Laney 
et al., 2010). The method described in this study meets these criteria. 
Additional methods to detect D. immitis DNA include deep sequencing (Fu et al., 
2013), high resolution melting (HRM) assay (Rojas et al., 2015), and nested PCR (Oi et 
al., 2015). The research outlined in this study along with current methodology provides a 
valuable tool for: 1) identifying mosquito vectors that are not already known in native 
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populations as well as those in different geographical regions, 2) clarifying the 
seasonality of transmission, 3) analysis of D. immitis gene regulation and 4) serving as a 
template for constructing parallel assays in other parasitic organisms. 
In the future, work with this L3 detection assay could include sensitivity testing, 
specificity testing, and field studies. Sensitivity levels can be measured by mixing single 
infective individual mosquitoes (14 d.p.i) with uninfected mosquitoes in a variety of total 
pool sizes (e.g., 5, 10, 15, 20 and 25 mosquitoes). This test would determine sensitivity 
limits by determining the minimum and maximum number of mosquitoes needed in a 
pool to detect infectivity. Furthermore, specificity of the L3 activated gene can be tested 
against other infective vector species pools within the three major genera Aedes, 
Anopheles and Culex that are considered to be competent vectors including Cx. pipiens 
and Ae. albopictus in addition to performing tests against other filarial parasites in 
endemic areas such as B. pahangi, B. malayi (Laney et al., 2010) and W. bancrofti (Laney 
et al., 2008) which are close evolutionary species. For example, Laney et al. (2010) 
demonstrated that the W. bancrofti collagen gene CK85571A met the criteria of no 
gDNA amplification and PCR efficiency but amplified transcripts from infective B. 
pahangi pools and was considered unsuitable as an L3 activated gene in regions where 
the two parasites might be co-endemic. These tests are important for studies involving 
field-collected mosquitoes. Additional studies are needed to evaluate its efficacy for 
interpreting the effects of control efforts.  
Dirofilaria immitis infections can be a public health concern as well as a major 
concern for animal health. Both canine and human dirofilariosis continue to be diagnosed 
within tropical, subtropical and temperate regions of the world (Vezzani et al., 2011; 
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Simón et al., 2012; Otranto et al., 2013). Little is known about the epidemiology and risk 
factors associated with human dirofilariosis (Dantas-Torres and Otranto 2013). Globally, 
most human cases of dirofilariosis are attributed to different Dirofilaria species (such as 
D. repens) rather than D. immitis (Simón et al., 2012). In the Americas, human 
dirofilariosis is primarily associated with D. immitis (Dantas-Torres and Otranto 2013). 
Several cases have been reported in North America including areas such as Texas and 
Florida (Theis 2005). This molecular assay demonstrates advancement in the “One 
Health” approach which embraces a cross-disciplinary collaborative effort between 
physicians, veterinarians, and scientists (including parasitologists and entomologists) to 
address diseases (e.g., rabies, Hendra virus, SARS, etc.) in which infection in one species 
can cause a disease in another (Gibbs 2014; Mellanby 2015). Understanding the biology 
of one species can help develop preventative approaches for another (Mellanby 2015). 
Considering the low frequency of documented human dirofilariosis cases reported actual 
occurrence could still be underestimated without advances in our ability to estimate 
transmission risks (Dantas-Torres and Otranto 2013). With a “One Health” approach the 
potential impact and benefits of both humans and animals will be considerable.
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Personal Protective measures 
I. Personal Protection 
1. Lab personnel will wear gloves and eye protection when working with biological 
material (including infectious agents). 
2. Lab personnel will wear appropriate foot-wear (closed-toe shoes) when working in the 
lab. 
3. Lab personnel will inform the principal investigator (Dr. Eric Chambers) if they are 
injured while working in the lab.  
4. A first aid kit is available in the lab for minor cuts and wounds. Lab personnel should 
still inform the principal investigator even for minor injuries. 
5. Lab personnel will be trained in the use of the chemical eye-wash station and the 
chemical shower station. 
6. Lab personnel will be trained in use of the chemical spill kit. 
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Decontamination Procedures 
I. Decontamination of work surfaces 
1. Work surfaces will be treated with 10% sodium hypochlorite for 2 minutes prior to 
initiation of work and following all work with infectious agents. 
2. Surfaces will then be wiped with paper towels.  
3. Lab personnel will wear gloves while carrying out decontamination protocols.  
 
II. Spills of potentially hazardous materials or hazardous waste (from VSU 
biohazard manual) 
 
General Principles 
1. Primary responsibility for preventing or/and containing and cleaning up laboratory 
spills remains with the principal investigator (Dr. Eric Chambers) or laboratory 
supervisor (Dr. Eric Chambers). Laboratory protocols should be carefully designed to 
prevent biological, chemical and/or radiation spills.  
2. When accidents occur that involve the mishandling or escape of biohazardous 
materials, the principal investigator or laboratory supervisor is to be notified 
immediately. Spills of high-risk organisms (certain Class 2 and all Class 3) should be 
reported to the Biosafety Officer during normal working hours or to the Valdosta St 
ate University Public Safety Division at the emergency telephone number after normal 
working hours by the principal investigator or laboratory supervisor. The Public 
Safety Division will contact the Biosafety Officer for appropriate response. All 
employees and/or students have an obligation to themselves and their colleagues to 
report accidents immediately in order to minimize potential hazard.  
3. When a biohazardous spill also involves radioactivity, cleanup procedures may have to 
be modified. The extent of the modification will depend on the level of radiation and 
the nature of the isotope involved. The Radiation Safety Officer should be called 
during normal working hours, or the Valdosta State University Public Safety Division 
should be called after normal working hours.  
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4. The attached guidelines are intended to assist the principal investigator, laboratory 
supervisor, and other responsible individuals who may be involved in the cleanup of 
biological spills.  
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Biohazardous Spills Inside Laminar Flow Biological Safety Cabinets (LFBSC) 
The occurrence of a spill in a biological safety cabinet poses less of a problem than a spill 
in an open laboratory as long as the spilled materials is contained in the biological safety 
cabinet. Decontamination of the work zone can usually be effected by direct application 
of concentrated liquid disinfectants along with a thorough wipe down procedure. Gaseous 
decontamination may be required to clean up the interior sections of the cabinet. 
 
Procedures for Decontamination of LFBSC 
1. Chemical decontamination procedures should be initiated immediately while the 
biological safety cabinet continues to operate. Continuing the operation of the LFBSC 
helps to prevent the escape of contaminants from the cabinet.  
2. Wearing protective gloves spray or wipe walls, work surfaces, and equipment with an 
appropriate decontaminating solution. A disinfectant detergent, such as Wescodyne or 
Environ has the advantage of detergent action on extraneous organic substances, 
which may interfere with the microbicidal activity of the disinfectant.  
3.  Flood tray top, drain pans, and catch basins below work surface with decontaminating 
solution and allow to stand for 20 minutes.  
4. Drain excess decontaminating solution from tray and drain pans into cabinet base. Lift 
out tray and removable exhaust grille work. Clean the top and bottom (underside) 
surfaces using a sponge or clean cloth soaked in decontaminant solution. Following 
the cleaning process, replace the tray and grille work in their proper position. Place 
gloves and sponge or cloth in autoclave pan and autoclave these items.  
5. Drain decontaminating solution from cabinet base into appropriate container and 
autoclave according to standard procedures.  
6. If gaseous decontamination of the cabinet’s interior sections is needed, call the 
Biosafety Officer.  
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Biohazardous Spills Outside Laminar Flow Biological Safety Cabinets  
The protocol to be used in cleaning up of spills involving microorganisms will depend on 
the amount of material spilled and the degree of laboratory containment required. If 
individuals believe that their outer garments have been contaminated, they should remove 
their clothing in the laboratory area and place them in an autoclave or a container for 
autoclaving. They should change into clean clothing in a non-contaminated area. All 
laboratory personnel should keep a complete change of clothing, including shoes at the 
laboratory in case of spills. Special care in decontamination may be necessary if a spill 
goes under or between fixed furniture or behind base moldings (floor/wall) or if floor 
penetrations are involved.  
 
Minor Spills (less than 10 ml and generating little aerosol) on equipment, laboratory 
benches, walls, or floors:  
 
1. Wipe up the spill with the soaked paper towels and place the used towels in an 
autoclave pan and autoclave.  
2. Pour decontaminating solution around and on the area of the spill. Let stand for 20 
minutes then wipe up with paper towels. Place gloves and paper towels in autoclave 
pan and autoclave.  
3. Wash hands and other apparently contaminated areas again with soap and water.  
 
Major Spills (more than 10 ml or with considerable aerosol): 
1. Close laboratory doors and post warning signs to prevent others from entering the 
laboratory.  
2. Wash hands and other apparently contaminated areas with soap and water.  
3. Report the accident to the Supervisor and to the Biosafety Officer.  
4. If personal clothing is contaminated, remove all outer clothing and place it in autoclave 
or container for autoclaving. Put on clean garments.  
5. Leave the laboratory for 20 minutes to allow dissipation of aerosols created by the 
spill.  
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6. Upon returning to the laboratory to start decontamination, check to see if laboratory 
doors are closed and appropriate signs are displayed. Put on surgical gloves. 
Respirators or other safety equipment may be required, depending on the 
microorganism involved. Check with the Principal Investigator or Laboratory 
Supervisor or Biosafety Officer.  
7. Pour a decontamination solution around the spill and allow this solution to flow into 
the spill. Paper towels soaked with decontamination solution may be used to cover the 
area. Do not pour decontamination solution directly onto the spill in order to avoid 
additional release of aerosols.  
8. Let decontamination solution – microorganism mixture stand for 20 minutes or longer 
to allow adequate contact time.  
9. Using autoclave dust pan and squeegee transfer all contaminated materials to deep 
autoclave pan, cover with suitable cover, and autoclave according to standard 
directions.  
10. Place dustpan and squeegee in an autoclavable bag and autoclave according to 
standard directions. 
11. Remove gloves and other contaminated garments and place them in an autoclave 
container for autoclaving.  
12. Thoroughly wash hands, face, and other apparently contaminated areas.  
 
Liquid Disinfectants 
Laboratory personnel should be familiar with the various disinfectants that will 
effectively kills the biohazardous agents being used. The following information is 
provided to assist in your selection of appropriate disinfectants. Alcohols– Ethyl and 
Isopropyl are good disinfectants for the vegetative forms of bacteria and  
enveloped viruses.  
 
Ethyl Alcohol 
1. Use Dilution: 70-95%  
2. Inactivates: vegetative bacteria and enveloped viruses, has variable results with non-
enveloped viruses and is ineffective with bacterial spores.  
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3. Other Characteristics: flammable, eye irritant, and toxic [Threshold limit value (TLV) 
– 1000 ppm]  
 
Isopropyl Alcohol  
1. Same as for Ethyl Alcohol except the TLV = 400 ppm.  
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Chlorine Compounds– The germicidal effect of chlorine compounds is dependent upon 
the release of hypochlorous acid and is therefore dependent upon the available chlorine.  
 
1. Allow a contact time of from 10 to 30 minutes.  
2. Use Dilution: 500 ppm available chlorine is recommended for vegetative bacteria and 
most viruses.  
3. Chlorine solutions that are neutral or slightly acidic and with a concentration of 
approximately 2500 ppm are needed for effectiveness against bacterial spores. 
Undiluted common household bleach (Clorox)is alkaline with a pH of 8. or greater. 
Household bleach typically contains 5.25% sodium hypochlorite for 52500 ppm 
available chlorine.  
4. Other Characteristics: Chlorine compounds are corrosive to metals; leave a residue; 
irritate the skin, eyes, and respiratory tract, and are toxic. Chlorine compounds are also 
rapidly inactivated by organic matter. While chlorine compounds are not generally 
recommended for routine use, undiluted household bleach is frequently used with 
biological spills.  
 
Iodophors - The germicidal effect of iodophors is dependent on the free iodine released 
from the compound in which it is contained. Allow a contact time of 10 to 30 minutes.  
 
1. Use Dilution: 25 to 1600 ppm of available iodine. Solutions containing 75 to 150 ppm 
are generally recommended.  
2. Inactivates: vegetative bacteria, fungi and viruses. There is poor activity against 
bacterial spores.  
3. Other Characteristics: Although iodophors are less harmful to man than chlorine 
compounds they can irritate the skin and eyes. Iodophors are corrosive (less than 
chlorine), they leave a residue and may stain. Iodophor stains, however, can be readily 
removed with solutions of sodium thiosulfate (Na2S2O3). As with the chlorine 
compounds, iodophors are rapidly inactivated by organic matter. One advantage is that 
iodophors have a built-in indicator. As long as the solution is brown or yellow it is still 
active. 
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Phenolic Compounds - These are effective against vegetative bacteria (including 
Mycobacterium tuberculosis), fungi, and enveloped viruses. Effectiveness against non-
enveloped viruses is variable depending on the virus. The phenols are ineffective against 
bacterial spores.  
 
1. Use Dilutions: 1.0 – 5.0% Solutions containing 0.5 – 2.0% phenol are effective against 
enveloped viruses.  
2. Other Characteristics: Phenols are corrosive and may leave a sticky, gummy residue.  
3. Phenolic compounds are irritating to the skin and eyes and are relatively toxic – Phenol  
4. TLV for skin is 5 ppm.  
 
Quaternary Ammonium Compounds – The efficacy of Quaternary Ammonium 
compounds still generates considerable controversy. Quats are effective in destroying 
ordinary vegetative bacteria and lipid containing virus but are not effective against 
Pseudomonas, Proteusand other gram-negative bacilli. Also, Quats are not effective 
against bacterial spores at the usual use concentrations of 1:750.  
 
1. Use Dilutions: 0.1 to 2.0%  
2. Other Characteristics: Quats are surface-active compounds which posses the useful   
    property of lowering the surface tension of the solution.  
3. Other advantages include being nontoxic, odorless, nonstaining, noncorrosive to metals  
    and stable. If used at recommended concentrations, Quats are nonirritating.  
4. Quaternary Ammonium compounds are rapidly inactivated by organic matter.  
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Occupational Health and Medical Surveillance of Human Dirofilariasis caused by 
Dirofilaria immitis 
 
I.  Background  
Human dirofilariasis is caused by infection with parasitic nematodes worms primarily 
from three species within the genus Dirofilaria; D. immitis, D. repens, and D. tenuis. 
Dirofilariasis is primarily a disease of domestic and wild animals. On rare occasions 
humans can be a spillover host, thus it us technically a zoonotic pathogen. 
 
II. Transmission 
Dirofilariasis requires transmission through an obligate mosquito vector. Dirofilariasis 
cannot be transmitted person-to-person nor can it be transmitted from humans to a 
mosquito and then back to humans. Because we will not be working with live infected 
mosquitoes in our facility, it is impossible for disease transmission to occur. 
 
III. Symptoms 
Human infections with D. immitis are can result in inflammation within the pulmonary 
arteries. These areas of inflammation often appear as coin lesions on x-rays. Human 
infection with D. immitis is most often asymptomatic but when symptoms do appear they 
include cough (can be a bloody cough), chest pain, and pleural effusion. 
 
IV. Medical Surveillance 
Personnel working with the frozen mosquitoes will be briefed on the pathogen D. 
immitis. All personnel will be instructed to tell their supervisor (Dr. Eric Chambers, if 
they are experiencing any of the symptoms described in part III). They will be instructed 
to relate their work history to physicians to avoid misdiagnosis of coin lesions (if such are 
observed on chest x-rays). 
 
V. Treatment 
No vaccine exists for dirofilariasis and in many cases no treatment with medicines is 
required. Surgical removal of lung granulomas is the definitive treatment. 
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Isolation of Total RNA from Tissue Samples 
Work under RNase-free conditions. 
This protocol is based on the Invitrogen protocol for total RNA isolation from any tissue 
sample using TRIzol LS reagent, and has been adapted for mosquito midgut tissue.  
Reagents required: 
-TRIzol LS Reagent (Invitrogen #10296-010) 
-Chloroform (without any additives, such as isoamyl alcohol) 
-Isopropyl alcohol 
-75% ethanol and 100% ethanol (in DEPC-treated water) 
-RNase-free water (DEPC-treated water)  
 -RNase inhibitor (40 units/μL, Invitrogen #10777-019) 
 
Homogenization  
Grind mosquito tissue (up to 30 adults or 60 midguts) using a blue pestle in a 1.5 mL tube 
with: 
250μl  RNase-free water 
750μl  TRIzol LS Reagent 
Incubate for 10 min at room temperature to permit the complete dissociation of 
nucleoprotein complexes. 
Phase Separation 
1. Add 200 μL of chloroform, shake tubes vigorously by hand for 15 s, and incubate 
at room temperature for 10 min.   
2. Centrifuge at 11,000 rpm (10,000 g) for 15 min at 4 °C. Following centrifugation,  
the mixture separates into a lower red, phenol-chloroform phase, an interphase, 
and a colorless upper aqueous phase. RNA remains exclusively in the aqueous 
phase. The volume of the aqueous phase is about 70% of the volume of TRIzol 
used for homogenization. 
RNA Precipitation 
1. Transfer the aqueous phase to a sterile tube containing 1 μL of RNase inhibitor 
(you can save the organic phase if isolation of DNA or protein is desired).  
Optional: to facilitate isolation of RNA from small quantities of sample, add 10-
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40 μg of RNase-free glycogen (Invitrogen #10814-010) as a carrier to the aqueous 
phase. 
2. Precipitate the RNA from the aqueous phase by adding 600 μL of cold isopropyl 
alcohol. Invert to mix, and incubate the samples for 15 min at room temperature. 
3. Centrifuge at 11,000 rpm for 10 min at 4 ºC. The RNA precipitate should be 
visible as a gel-like pellet on the side and bottom of the tube.  
RNA Wash 
1. Remove the supernatant.   
2. Wash the RNA pellet with 1 mL of cold 75% ethanol. Mix the sample by gentle 
vortexing. 
3. Centrifuge at 9,000 rpm (7,000 x g) for 5 min at 4 °C. 
4. Wash the RNA pellet another time with 500 μL of cold 100% ethanol. 
5. Centrifuge at 9,000 rpm for 2 min at 4 ºC.   
RNA Resuspension 
1. Remove the ethanol with a pipet and air-dry the RNA pellet for 5-10 min. Do not  
dry the RNA by centrifugation under vacuum. It is important not to let the RNA 
pellet dry completely as this will greatly decrease its solubility. Partially dissolved 
RNA samples have an A260/A280 ratio <1.6.    
2. Dissolve the RNA in RNase-free TE, pH 8.0 (10-100 μL, depending on amount of 
RNA) by incubating for 10 min at 60 ºC. Add 1 μL RNase inhibitor for long-term 
storage at -80 ºC. 
 
  
